Literature DB >> 29168282

Risk factors for asthma occurrence in children with early-onset atopic dermatitis: An 8-year follow-up study.

Ching-Chun Huang1,2, Tung-Liang Chiang3, Pau-Chung Chen1,2, Shio-Jean Lin4, Hui-Ju Wen5, Yue Leon Guo1,2,5.   

Abstract

BACKGROUND: Children with early-onset atopic dermatitis (AD) are at substantial risk of developing asthma later in life, and identifying the critical window of detrimental exposure is advantageous for implementing preventive actions. The aim of this study was to evaluate the role of exposure to environmental modifiers during pregnancy and early childhood in asthma occurrence in an infantile AD cohort.
METHODS: Eligible study participants were selected from the Taiwan Birth Cohort Study, which enrolled 24 200 newborns in 2005. We enrolled those cases who had been diagnosed as having AD before 3 years of age and followed them up till age 8. We excluded those ever diagnosed with asthma before AD onset. The dependent variable was defined in terms of whether the participant was diagnosed as having asthma before 8 years of age. We applied logistic regression models to evaluate the risks of exposure to different determinants in asthma occurrence.
RESULTS: A total of 1549 children with AD had completed the 8-year follow-up, and 334 (21.6%) of them had asthma. The results revealed that male sex, lower birth order, maternal asthma history, maternal obesity before pregnancy, and environmental tobacco smoke exposure before 3 years of age were significant risk factors for further development of asthma. Furthermore, food allergy during early life, lower respiratory tract infection, and longer durations of symptomatic AD influenced asthma development later in life.
CONCLUSIONS: The findings confirmed the critical determinants for asthma occurrence in infantile AD, which may enable a more personalized approach to the prevention of asthma.
© 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  Taiwan Birth Cohort Study; environmental tobacco smoke; food allergy; obesity; pregnancy

Mesh:

Year:  2017        PMID: 29168282     DOI: 10.1111/pai.12835

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway.

Authors:  Xueying Li; Zhaoqing Han; Feng Wang; Jianou Qiao
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-17       Impact factor: 3.406

2.  Maternal obesity, gestational weight gain, and offspring asthma and atopy.

Authors:  Kristen J Polinski; Griffith A Bell; Mai-Han Trinh; Rajeshwari Sundaram; Pauline Mendola; Sonia L Robinson; Erin M Bell; Temilayo Adeyeye; Tzu-Chun Lin; Edwina H Yeung
Journal:  Ann Allergy Asthma Immunol       Date:  2022-05-10       Impact factor: 6.248

3.  Prenatal perfluorooctanoic acid exposure and glutathione s-transferase T1/M1 genotypes and their association with atopic dermatitis at 2 years of age.

Authors:  Hui-Ju Wen; Shu-Li Wang; Pau-Chung Chen; Yue Leon Guo
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

Review 4.  Risk factors of asthma in the Asian population: a systematic review and meta-analysis.

Authors:  Yang Yie Sio; Fook Tim Chew
Journal:  J Physiol Anthropol       Date:  2021-12-09       Impact factor: 2.867

Review 5.  Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata.

Authors:  Yoko Minokawa; Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

Review 6.  Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring.

Authors:  Merve Denizli; Maegan L Capitano; Kok Lim Kua
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

Review 7.  Daily Lifestyle and Inflammatory Skin Diseases.

Authors:  Yu Sawada; Natsuko Saito-Sasaki; Emi Mashima; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.